Arteriogenesis and therapeutic angiogenesis / / edited by Paul Quax, Elisabeth Deindl.

Although advances in therapeutic interventions improved outcomes, vascular occlusive diseases are still challenging not only afflicted but also attending physicians, requiring novel therapeutic strategies. Arteriogenesis, sometimes also called therapeutic angiogenesis, refers to the body's own...

Full description

Saved in:
Bibliographic Details
TeilnehmendeR:
Place / Publishing House:Basel, Switzerland : : MDPI - Multidisciplinary Digital Publishing Institute,, 2022.
Year of Publication:2022
Language:English
Physical Description:1 online resource (220 pages)
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993603470604498
ctrlnum (CKB)5400000000043757
(NjHacI)995400000000043757
(EXLCZ)995400000000043757
collection bib_alma
record_format marc
spelling Arteriogenesis and therapeutic angiogenesis / edited by Paul Quax, Elisabeth Deindl.
Basel, Switzerland : MDPI - Multidisciplinary Digital Publishing Institute, 2022.
1 online resource (220 pages)
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
Description based on publisher supplied metadata and other sources.
Although advances in therapeutic interventions improved outcomes, vascular occlusive diseases are still challenging not only afflicted but also attending physicians, requiring novel therapeutic strategies. Arteriogenesis, sometimes also called therapeutic angiogenesis, refers to the body's own capacity to create a natural bypass around a narrowing or occluded arterial vessel. This book gives an insight into current knowledge and advances in vascular sciences and future prospects of therapeutic options. The utility and relevance of circulating biomarkers together with the potential of machine learning methods are discussed as well as the challenges and prospects of novel therapies such as protein- gene-, and stem cell therapy along with multicistronic multigene vectors and the use of microRNAs, exosomes, and secretomes. Vascular smooth muscle phenotype switch as a target to promote arteriogenesis is critically addressed, highlighting the problem of promoting atherosclerosis in parallel. Two articles even deal with cold-inducible RNA-binding protein CIRP/CIRPB presenting it as promising target to promote vascularization concomitant the reduction in ischemic tissue damage. BMPR kinase inhibition is introduced to improve tissue repair in a hereditary form of vascular disorder, and the role of the AP-1 transcription factor JunB in blood vessel formation is described. Some more experimental oriented articles deal with the relevance of choosing the appropriate mouse strain for investigations as well as in vitro Matrigel plug assay as a potent method to investigate angiogenesis. Last but not least, two-photon intravital microscopy is presented as suitable tool to assess plaque angiogenesis in atherosclerotic lesions.
Medicine Practice.
Medicine Early works to 1800.
3-0365-2716-8
Quax, Paul, editor.
Deindl, Elisabeth, editor.
language English
format eBook
author2 Quax, Paul,
Deindl, Elisabeth,
author_facet Quax, Paul,
Deindl, Elisabeth,
author2_variant p q pq
e d ed
author2_role TeilnehmendeR
TeilnehmendeR
title Arteriogenesis and therapeutic angiogenesis /
spellingShingle Arteriogenesis and therapeutic angiogenesis /
title_full Arteriogenesis and therapeutic angiogenesis / edited by Paul Quax, Elisabeth Deindl.
title_fullStr Arteriogenesis and therapeutic angiogenesis / edited by Paul Quax, Elisabeth Deindl.
title_full_unstemmed Arteriogenesis and therapeutic angiogenesis / edited by Paul Quax, Elisabeth Deindl.
title_auth Arteriogenesis and therapeutic angiogenesis /
title_new Arteriogenesis and therapeutic angiogenesis /
title_sort arteriogenesis and therapeutic angiogenesis /
publisher MDPI - Multidisciplinary Digital Publishing Institute,
publishDate 2022
physical 1 online resource (220 pages)
isbn 3-0365-2716-8
callnumber-first R - Medicine
callnumber-subject R - General Medicine
callnumber-label R117
callnumber-sort R 3117 A784 42022
genre_facet Early works to 1800.
illustrated Not Illustrated
dewey-hundreds 600 - Technology
dewey-tens 610 - Medicine & health
dewey-ones 610 - Medicine & health
dewey-full 610.8
dewey-sort 3610.8
dewey-raw 610.8
dewey-search 610.8
work_keys_str_mv AT quaxpaul arteriogenesisandtherapeuticangiogenesis
AT deindlelisabeth arteriogenesisandtherapeuticangiogenesis
status_str n
ids_txt_mv (CKB)5400000000043757
(NjHacI)995400000000043757
(EXLCZ)995400000000043757
carrierType_str_mv cr
is_hierarchy_title Arteriogenesis and therapeutic angiogenesis /
author2_original_writing_str_mv noLinkedField
noLinkedField
_version_ 1796653217976680448
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02811nam a2200313 i 4500</leader><controlfield tag="001">993603470604498</controlfield><controlfield tag="005">20230623221714.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">230623s2022 sz o 000 0 eng d</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.3390/books978-3-0365-2717-8</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5400000000043757</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)995400000000043757</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995400000000043757</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">R117</subfield><subfield code="b">.A784 2022</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610.8</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Arteriogenesis and therapeutic angiogenesis /</subfield><subfield code="c">edited by Paul Quax, Elisabeth Deindl.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Basel, Switzerland :</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute,</subfield><subfield code="c">2022.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (220 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on publisher supplied metadata and other sources.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Although advances in therapeutic interventions improved outcomes, vascular occlusive diseases are still challenging not only afflicted but also attending physicians, requiring novel therapeutic strategies. Arteriogenesis, sometimes also called therapeutic angiogenesis, refers to the body's own capacity to create a natural bypass around a narrowing or occluded arterial vessel. This book gives an insight into current knowledge and advances in vascular sciences and future prospects of therapeutic options. The utility and relevance of circulating biomarkers together with the potential of machine learning methods are discussed as well as the challenges and prospects of novel therapies such as protein- gene-, and stem cell therapy along with multicistronic multigene vectors and the use of microRNAs, exosomes, and secretomes. Vascular smooth muscle phenotype switch as a target to promote arteriogenesis is critically addressed, highlighting the problem of promoting atherosclerosis in parallel. Two articles even deal with cold-inducible RNA-binding protein CIRP/CIRPB presenting it as promising target to promote vascularization concomitant the reduction in ischemic tissue damage. BMPR kinase inhibition is introduced to improve tissue repair in a hereditary form of vascular disorder, and the role of the AP-1 transcription factor JunB in blood vessel formation is described. Some more experimental oriented articles deal with the relevance of choosing the appropriate mouse strain for investigations as well as in vitro Matrigel plug assay as a potent method to investigate angiogenesis. Last but not least, two-photon intravital microscopy is presented as suitable tool to assess plaque angiogenesis in atherosclerotic lesions.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Medicine</subfield><subfield code="x">Practice.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Medicine</subfield><subfield code="v">Early works to 1800.</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-0365-2716-8</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Quax, Paul,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Deindl, Elisabeth,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-07-06 03:14:28 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-04-04 09:22:53 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5338122340004498&amp;Force_direct=true</subfield><subfield code="Z">5338122340004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338122340004498</subfield></datafield></record></collection>